SCHEMBL3406257

SCHEMBL3406257

CCOC(=O)c1sc(N)nc1-c1cc(OC)ccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.58
HSD17B10 Q99714 4/20 0.58
FBP1 P09467 1/20 0.50
CYP1A2 P05177 1/20 0.50
CDC7 O00311 7/20 0.48
DBF4 Q9UBU7 7/20 0.48
HPGD P15428 5/20 0.47
ALOX15 P16050 2/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 2/20 0.46
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
CASP3 P42574 1/20 0.46
RAB9A P51151 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399807 0.86 CDC7 (0.51) ALDH1A1HSD17B10CDC7DBF4HPGD
SCHEMBL18236334 0.82 ALDH1A1 (0.69) ALDH1A1HSD17B10FBP1CYP1A2CDC7
SCHEMBL17844015 0.80 ALDH1A1 (0.59) ALDH1A1HSD17B10FBP1CYP1A2CDC7
SCHEMBL509072 0.80 CDC7 (0.62) ALDH1A1HSD17B10FBP1CYP1A2CDC7
SCHEMBL28723241 0.79 ALDH1A1 (0.76) ALDH1A1HSD17B10FBP1CYP1A2CDC7
SCHEMBL3406707 0.79 ALDH1A1 (0.60) ALDH1A1HSD17B10FBP1CYP1A2CDC7
SCHEMBL1505583 0.76 ALDH1A1 (0.67) ALDH1A1HSD17B10FBP1CYP1A2CDC7
SCHEMBL3406570 0.76 ALDH1A1 (0.57) ALDH1A1HSD17B10FBP1CYP1A2CDC7
SCHEMBL3401335 0.76 ALDH1A1 (0.60) ALDH1A1HSD17B10FBP1CYP1A2CDC7
SCHEMBL3433741 0.76 ALDH1A1 (0.60) ALDH1A1HSD17B10FBP1CYP1A2CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2158199-B1 PIPERIDINE COMPOUNDS AND USES THEREOF ASTRAZENECA AB (SE) 2010-11-17 EP disclosed
EP-2158199-B1 PIPERIDINE COMPOUNDS AND USES THEREOF ASTRAZENECA AB (SE) 2010-11-17 EP disclosed
WO-2008152418-A1 PIPERIDINE COMPOUNDS AND USES THEREOF ASTRAZENECA AB (SE) 2008-12-18 WO disclosed
US-20080312255-A1 PIPERDINE COMPOUNDS AND USES THEREOF-911 ASTRAZENECA AB (SE) 2008-12-18 US disclosed
US-20080312255-A1 PIPERDINE COMPOUNDS AND USES THEREOF-911 ASTRAZENECA AB (SE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312255-A1 PIPERDINE COMPOUNDS AND USES THEREOF-911 NISCH, PIR, QDPR ALDH1A1 243/4885HSD17B10 4653/4885FBP1 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.